Robert J. Mulroy
Founder at Partner Therapeutics, Inc.
Robert J. Mulroy active positions
| Companies | Position | Start | End |
|---|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Founder | - | - |
Career history of Robert J. Mulroy
Former positions of Robert J. Mulroy
| Companies | Position | Start | End |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Director/Board Member | 26/01/2011 | 02/10/2016 |
| Chief Executive Officer | 30/04/1999 | 02/10/2016 | |
| President | 30/04/1999 | 02/10/2016 |
Training of Robert J. Mulroy
| Stanford University | Undergraduate Degree |
| Yale University | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Robert J. Mulroy
- Experience